The prostate-specific PCA3 gene encodes a non-coding RNA that exhibits up to a 66-fold upregulation in prostatic tumours, with studies showing it to be present in >90% of PC cases [207,208,209]. The gene discussed is PCA3; the disease is pachyonychia congenita.